After the most recent news of the termination of the original Rite Aid (RAD)/Walgreens (WBA) deal set forth in October 2015, investors have found their stock price halved during the merger saga which eventually ended up in a broken deal.
A new batch of seemingly fresh investors have come onboard the Rite Aid train proclaiming that this new revised deal bodes well for Rite Aid and that investors should start accumulating shares in light of all the uncertainty.
For those investors who have followed my writing, I predicted a fall to the $2 range upon a failed merger.
